![Ryan Asay](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Ryan Asay worked as a Director of Investor Relations at Bristol Myers Squibb Co. He then worked as the Head of Investor Relations at Spark Therapeutics, Inc. from 2017 to 2020.
From 2020 to 2024, he worked as the Vice President and Head of Corporate Affairs at Mirati Therapeutics, Inc.
Antiguos cargos conocidos de Ryan Asay.
| Empresas | Cargo | Fin |
|---|---|---|
| MIRATI THERAPEUTICS | Corporate Officer/Principal | 23/01/2024 |
| SPARK THERAPEUTICS, INC. | Contacto de Relaciones con Inversores | 01/02/2020 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
21
Relaciones de 1er grado
2
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
- Bolsa de valores
- Insiders
- Ryan Asay
Elige MarketScreener 
